• Home
  • News
  • Fortune 500
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
    • Great Place to Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • FORTUNE 500
    • FORTUNE 500
    • FORTUNE SEA 500
    • Fortune 500 Europe
    • Fortune Global 500
    • Fortune China 500
    • Great Place to Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Banking
    • Investing
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics
  1. home
  1. home
  2. Amgen

Amgen

Page 2 of 2

An Amgen sign is seen at the company's office in South San Francisco
Health

Amgen Is Taking On a $3 Billion Cancer Drug. But Will It Cut Costs for Patients?

By Sy Mukherjee
September 15, 2017
Trading On The Floor Of The NYSE As U.S. Stocks Rise Amid Stronger Job Gains Boost Optimism On Economy
Health

This Biotech’s Stock Plunged 24% After the FDA Rejected Its Amgen Drug Copycat

By Sy Mukherjee
June 12, 2017
Elektrocardiogram
Health

A Heart Attack-Prevention Drug Disappoints…Wall Street

By Clifton Leaf
March 17, 2017
These 3 Ugly Patent Battles Could Rock Biopharma’s 2017
Health

These 3 Ugly Patent Battles Could Rock Biopharma’s 2017

By Sy Mukherjee
January 7, 2017
The Davos World Economic Forum 2015
Health

Novartis Just Got Some Great News in Its Battle for Amgen’s Market Share

By Sy Mukherjee
August 31, 2016
The Davos World Economic Forum 2015
Health

Amgen Finally Scores a Win in Its Big Copycat Drug Battle With Novartis

By Sy Mukherjee
July 19, 2016
Close up of surgical tools and money
Health

Two of the World’s Best-Selling Drugs Are Headed for a Lot More Competition

By Sy Mukherjee
July 15, 2016
483106863
Health

Drug Companies Really Don’t Care About the Price Hike Backlash

By Sy Mukherjee
July 14, 2016
The Powerful And Influential Attend Clinton Global Initiative Annual Meeting
Health

Merck to Axe Jobs As Part of New Research Focus

By Sy Mukherjee
July 13, 2016
Pharmacy technician Andrea Tibbetts counts out pills to fill an order for generic medications at Por
Health

This Is the Most Important Business Trend in Pharma

By Sy Mukherjee
June 21, 2016
FRANCE-ECONOMY-PHARMACEUTICALS-SANOFI
Health

Sanofi Is Shuffling Its Exec Roster Amid Continued Struggles

By Sy Mukherjee
May 23, 2016
155292424
Health

Another Major Insurer Is Tying Drug Prices to Health Outcomes

By Sy Mukherjee
May 11, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
Finance

Biotech Stocks Are Down 25% So Far This Year

By Sy Mukherjee
May 6, 2016
An Amgen sign is seen at the company's office in South San Francisco
Health

Amgen Just Won a Major Drug Patent Case Against Its Rivals

By Sy Mukherjee
March 16, 2016
Daniel Loeb urges Amgen to split into two companies
Finance

Daniel Loeb urges Amgen to split into two companies

By Reuters
October 21, 2014

Most Popular

  • AI
    'Godfather of AI' says the technology will create massive unemployment and send profits soaring — 'that is the...
    By Jason Ma
  • Success
    Be careful boomers, your Gen Z coworker may be recording you — 9-to-5s aren’t just about climbing the ladder, they’re...
    By Jessica Coacci
  • Economy
    Mortgage rates plunge to 11-month low on Fed rate cut hopes, and many lenders may quote in the high 5% range
    By Jason Ma
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Fortune
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.